Angela Lee Diversion Investigators DRUG ENFORCEMENT ADMINISTRATION Jackson, Mississippi
|
|
- Spencer Stone
- 7 years ago
- Views:
Transcription
1 DRUG ENFORCEMENT ADMINSTRATION Guide to Prescription Fraud &Diversion
2 Angela Lee Diversion Investigators DRUG ENFORCEMENT ADMINISTRATION Jackson, Mississippi
3 Office of Diversion Control Regulatory and Administrative Responsibility Investigative Responsibility for enforcement of the Unites States Code (criminal or civil) and the Code of Federal Regulations
4 DEA s Dual Role Maintain closed system of controlled substance and listed chemical record keeping... Conduct investigations on the diversion of controlled substances and listed chemicals into the black market...
5 WHAT IS DIVERSION THE DIVERTING OF LEGITMATE CONTROLLED SUBSTANCES or LISTED CHEMICALS INTO THE BLACK MARKET; GOVERNED BY FEDERAL LAW/DEA AUTHORITY; ALSO GOVERNED BY STATE LAW;
6 CONTROLLED PREMISES DEFINITION controlled via CFRs DEA AUTHORITY CONTROLLED PREMISE AND REGISTERED LOCATION ARE THE SAME
7 PRESCRIPTION REFILLS SCHEDULE 3, 3N,4, 4N, AND 5 ORIGINAL Rx WITH 5 REFILLS IN A 6 MONTH PERIOD IS ALLOWED PRESCRIPTION CAN BE TELEPHONED
8 Controlled Substance Dispensing vs. Administering Federal Requirement - Follow state laws and regulations DEA Registration must concur with state authorized activities...
9 Acquiring by Fraud, Deceit, etc. Forged Prescriptions Altered prescriptions False called in prescriptions Doctor Shopping /acquire large amounts The attempt establishes criminal intent and is a chargeable crime
10 Types of Fraudulent Prescriptions Stolen Rx Pads (Charity Hospital, etc.) Altered Rx s Altered physician call back number False call-in Rx s by suspects Computer generated Rx s atsuspects home
11 INDICATIONS THAT RX S ARE NOT LEGITIMATE AMOUNT HIGHER THAN USUAL REFILLS ARE BEING ACQUIRED SOONER THAN THE AMOUNT IS PRESCRIBED FOR SUSPECT PRESENTS RX S IN THE NAMES OF OTHER PERSONS
12 CHARECTERISTICS OF FORGED RX S RX LOOKS TOO GOOD / TOO LEGIBLE QUANTITIES OR DOSAGES DIFFER FROM USUAL MEDICAL DOSAGES RX DOESN T HAVE THE USUAL ABREVEATIONS RX APPEARS TO BE PHOTOCOPIED RX WRITTEN IN DIFFERENT COLOR INKS OR APPEAR TO HAVE DIFFERENT HANDWRITING
13 Title 21 United States Code Illegal distribution 841(a)(1) Illegal Dispensing for registrants using their professional authority to participate, aid and assist in the diversion of pharmaceuticals
14 Title 21 United States Code 843(a)(3) Acquisition of Controlled Substances by Fraud, etc; Federal law may not be applied below minimum threshold amounts; State t law will apply in most cases since each state can effect laws that are more restrictive ti than the federal law - Constitutional Sovereignty
15 Possession of Rx Form For a Controlled Substance or Legend Drug; Legend Drug is one which is not controlled, o but requires es a Rx to be filled Verify Ownership Suspect must have the express consent of the person in whose name the Rx was written for...
16 PAIN MANAGEMENT PRACTITIONERS ARE NOT LIMITED LEGITIMATE MEDICAL PURPOSE *STATED TREATMENT GOALS AND FOLLOW-UP DEA INVESTIGATIONS DR. SHOPPERS/ OBTAINING BY FRAUD SCAMS
17 Myth of the Chilling Effect Vast Majority of Practioners Comply with rules and regulations DEA Investigations are based on facts determined from said investigations... Since FY 1999: Approx. one million registered doctors - DEA has had sanctions pursued upon less than one tenth of 1%...
18 NTP S RELIEF OF PAIN METHADONE SUBJECT TO HIGH ABUSE SCHEDULE II 40mg Diskettes voluntarily removed from marketplace due to abuse provided only to NTPs; Not FDA approved for pain mgt.
19 NTP GUIDELINES FOR M.D. S 3 DAY RULE ADJUNCT TO MEDICAL TREATMENT ADMINISTERED NOT PRESCRIBED Buprenorphine products can be prescribed or administered by authorized physicians
20 INTERNET PRESCRIBING DR. / PATIENT RELATIONSHIP SUBJECT TO ABUSE NEGATIVE PUBLICITY LICENSURE IN ALL JURISDICTIONS WHERE PATIENTS ARE LOCATED
21 POTENTIAL HEALTH RISKS IN INTERNET PRESCRIBING Adverse drug reactions/interactions Misdiagnosis or delay in diagnosis Failure to identify complicating conditions
22 WHERE TO GATHER INFORMATION FOR INVESTIGATION RX FORM REQUIREMENTS RX BOTTLE LABELS VERIFY SUSPECT STORY/MAKE TELEPHONE INQUIRIES FACE TO FACE INTERVIEW WITH PHYSICIAN AND STAFF WHEN POSSIBLE INTERVIEW OF PHARMACIST AND STAFF WHEN POSSIBLE
23 On Scene Investigation Do the basics of verifying Rx with physician Get statement from pharmacist and physician Verify DEA Registration Number Get actual RX form for evidence from pharmacy Verify handwriting (handwriting exemplar) Get written disclaimer on Rx form from DR.
24 Acquiring Documentary Evidence at Pharmacies Subpoena Deuces Tecum from District Attorney s Office Pres. Monitoring Prog. Ask for DEA assistance if possible - Service of Notice of Inspection Grand Jury Subpoenas Always provide a receipt for any documents taken as evidence; return documents upon completion of prosecution...
25 Common Characteristics of the Drug Abuser Unusual behavior in the waiting room Assertive personality, often demanding immediate service Unusual appearance, extreme slovenliness or over dressed d May have unusual knowledge of controlled substances or gives medical history with textbook symptoms or gives evasive or vague answers to questions on their medical history
26 Characteristics Continued Reluctant or unwilling to provide information, usually has no regular doctor or health insurance, pays in cash Will request specific controlled substances by name, and won t try a different drug\ Has no interest in diagnosis, fails to keep appointments, t refuses to see a specialists May exhibit mood swings, suicidal thoughts, lack of impulse control
27 MO Used by Drug Abusers Must be seen right away, anxious, nervous Wants an appointment at the end of the day Calls or comes in after regular hours Traveling through town, visiting friends or relatives, not a permanent resident Feigning physical problems, such as abdominal or back pain, kidney stones, migraine headaches
28 MO Continued Feigning psychological problems, anxiety, insomnia, fatigue or depression States that specific non-narcotic narcotic analgesics don t work or they are allergic to them Claims to be a patient of a practitioner who is not available or they will not give the name of their primary physician
29 MO Continued Claims a prescription has been lost or stolen Requests early refills Pressures the practitioner with sympathy or guilt or direct threats t Uses a child or elderly person when seeking methylphenidate or pain medication
30 What to do When Confronted by DO: a Suspected Drug Abuser Perform a thorough examination appropriate to the condition Document examination results and questions you asked the patient t Request a picture ID and social security number, photocopy and keep in medical file Call a previous practitioner, pharmacist or hospital to confirm the patient s story
31 DO Continued Confirm telephone number of patient Confirm current address of patient Write Wit prescriptions for a limited it amount Limit refills
32 What not to do DON T Take the patients word for it Dispense drugs just to get rid of drug seeking patients Prescribe, dispense or administer controlled substances outside the scope of your professional practice or in the absence of a practitioner-patient patient relationship
33 Responsibilities Legal and ethical responsibility to uphold the law and protect society from drug abuse Professional responsibility to prescribe and dispense controlled substances appropriately Personal responsibility to protect t your practice from becoming easy target
34 Potential Penalties Letter of Admonition Civil Fines Ci Criminal i lp Prosecution Revocation
35 For Further Information, contact the: Jackson District Office Diversion Group Contact Us at: (601) or jg
Drug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
More informationFederal Regulations For Prescribing Scheduled Controlled Substances
Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system
More informationNarcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
More information12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
More information2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program
PMP Center of Excellence Notes from the Field 2.1 Staying Clear of the Law and Addiction: Nevada s Pre- Criminal Intervention Program January 2011 This project was supported by Grant No. 2006-DG-BX-K071
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationCHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No.
CHAPTER 2010-211 Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. 2722 An act relating to controlled substances; amending s. 456.037,
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationMedicare Compliance and Fraud, Waste, and Abuse Training
Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques
More information13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of
More informationMODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING
MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING 2 0 1 4 Introduction The Medicare and Medicaid programs are governed by statutes, regulations, and policies PacificSource must have an effective
More informationDEA Washington Division Diversion Control Program
SOUTHWEST VIRGINIA PRESCRIPTION DRUG ABUSE SUMMIT DEA Washington Division Diversion Control Program Mary Johnson-Rochee Diversion Program Manager November 14, 2012 Topics: DEA s Diversion Mission How DEA
More informationAchieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
More informationMedicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
More informationWhat Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
More informationDeveloped by the Centers for Medicare & Medicaid Services
Developed by the Centers for Medicare & Medicaid Services Every year millions of dollars are improperly spent because of fraud, waste, and abuse. It affects everyone. Including YOU. This training will
More informationHow To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More information1) ELIGIBLE DISCIPLINES
PRACTITIONER S APPLICABLE TO ALL INDIVIDUAL NETWORK PARTICIPANTS AND APPLICANTS FOR THE PREFERRED PAYMENT PLAN NETWORK, MEDI-PAK ADVANTAGE PFFS NETWORK AND MEDI-PAK ADVANTAGE LPPO NETWORK. 1) ELIGIBLE
More informationSUBCHAPTER IV. OFFENSES AND PENALTIES
DISTRICT OF COLUMBIA OFFICIAL CODE TITLE 48. FOOD AND DRUGS SUBTITLE III. ILLEGAL DRUGS CHAPTER 9. CONTROLLED SUBSTANCES UNIT A. CONTROLLED SUBSTANCES ACT SUBCHAPTER IV. OFFENSES AND PENALTIES 48-904.01.
More information02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
More informationSCOPE OF PRACTICE FOR ARNPS
FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow
More informationFraud, Waste, and Abuse
These training materials are divided into three topics to meet the responsibilities stated on the previous pages: Fraud, Waste, Compliance Program Standards of Conduct Although the information contained
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More information11/26/2012. Implementation of Florida s PDMP. Disclosure
Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or
More informationDrug-Free Workplace Policy and Procedures July 16, 2015
Drug-Free Workplace Policy and Procedures July 16, 2015 Regional Transit Authority of Southeast Michigan Drug-Free Workplace Policy and Procedures Purpose In compliance with regulations governing anti-drug
More informationCIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS
CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD Kelly Raker 310 Ezzard Charles Dr. Cincinnati, OH 45214 513-564-2233
More informationDIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY
DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:
More informationOBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program
Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department
More informationMedicare Advantage and Part D Fraud, Waste and Abuse Compliance Training
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related entities
More informationOpioid Contracts: A Tool for Providing Relief and Preventing Abuse?
Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate
More informationPOLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL
PURPOSE POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL To outline the procedures used in recognizing and providing
More informationINFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS
INFORMATION EXCHANGE IN PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) LEGAL ISSUES REGARDING ACCESS AND DISCLOSURE SHERRY L. GREEN, CEO NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS NATIONAL CONFERENCE OF
More informationElectronic Prescribing In New York State
Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe
More informationDo You Know Where the Drugs Are Going?
Do You Know Where the Drugs Are Going? Presentation Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at least four
More information"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee
DEA Congressional Testimony December 4, 2007 Statement of Joseph T. Rannazzisi Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration "Electronic Prescribing of Controlled
More information1 st Tier & Downstream Training Focus
Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste
More informationLEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING
More information5530 SUBSTANCE ABUSE (M)
Haddonfield 5530 / Page 1 of 10 5530 SUBSTANCE ABUSE (M) The following procedures are established in implementation of Policy No. 5530, Substance Abuse. A. Definitions 1. Evaluation means those procedures
More informationFraud Waste and Abuse Training Requirement. To Whom It May Concern:
RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)
More informationPharmacy Law Overview. From Civil Liability to Criminal Prosecution
Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy
More informationTEXAS ~ STATUTE Continued
TEXAS ~ STATUTE STATUTE DATE Enacted 1981 REGULATORY BODY Texas Rev. Civ. Stat., Occupations Code, Chapter 204: Physician Assistant Licensing Act; Occupations Code Chapter 157; Authority of Physician to
More informationMedicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies
Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies 2008 Medco Health Solutions, Inc. All rights reserved. Training Introduction In this training, you ll learn
More informationHP1616, LD 2253, item 1, 123rd Maine State Legislature An Act To License Certified Professional Midwives
PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney. Be it enacted by the People of the
More informationImplementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
More informationFraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011
Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your
More informationHow To Deal With A Pupil Who Is Under The Influence Of Alcohol Or Drugs
R 5530/Page 1 of 12 R 5530 The following procedures are established in implementation of Policy No. 5530, Substance Abuse. A. Definitions 1. Evaluation means those procedures used by a certified or licensed
More informationArkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
More information"HAWAII ADMINISTRATIVE RULES TITLE 11 DEPARTMENT OF HEALTH CHAPTER 160 MEDICAL USE OF MARIJUANA. Debilitating Medical Conditions
"HAWAII ADMINISTRATIVE RULES TITLE 11 DEPARTMENT OF HEALTH CHAPTER 160 MEDICAL USE OF MARIJUANA Subchapter 1 General Provisions 11-160-1 Purpose 11-160-2 Definitions 11-160-3 Severability 11-160-4 Disclaimer
More informationOregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:
Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain
More informationPhysician Information. Answers to Frequently Asked Questions
Page 31 Physician Information Answers to Frequently Asked Questions Who is qualified to prescribe SUBOXONE or SUBUTEX? Physicians who: Meet one or more of the following training requirements Hold a subspecialty
More informationDo You Know Where the Drugs Are Going? Partners in Integrity
Do You Know Where the Drugs Are Going? Partners in Integrity Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at
More informationTouchstone Health Training Guide: Fraud, Waste and Abuse Prevention
Touchstone Health Training Guide: Fraud, Waste and Abuse Prevention About the Training Guide Touchstone is providing this Fraud, Waste and Abuse Prevention Training Guide as a resource for meeting Centers
More informationSubject: Health; prescription drugs; Vermont Prescription Monitoring 5 System
0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill
More information2013 Medicare. Part D Fraud, Training. First Tier, Downstream and Related Entities
2013 Medicare Advantage and Part D Fraud, Waste and Abuse Waste, Training First Tier, Downstream and Related Entities February, 2013 Training Objectives 1 Why is Fraud, Waste, and Abuse (FWA) Training
More informationADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN
Janice K. Brewer Governor Arizona State Board of Nursing 4747 North 7 th Street, Suite 200 Phoenix, AZ 85014-3655 Phone (602) 889-5150 Fax - (602) 889-5155 E-Mail: arizona@azbn.gov Home Page: http://www.azbn.gov
More informationAdopted Rule - 11/19/14 1
Adopted Rule - 11/19/14 1 CHAPTER Ph 800 PHARMACY TECHNICIANS Statutory Authority: RSA 318:5-a, X, XI Adopt Ph 801 & Ph 802, previously effective 7-25-01 (Doc. # 7535) and expired on 7-25-09, to read as
More informationDEA REGISTRATION FEES FACT SHEET
DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants
More informationManitoba Prescribing Practices Program Pharmacist Questions and Answers
College of Pharmacists of Manitoba 200 Tache Avenue, Winnipeg, Manitoba R2H 1A7 Phone (204) 233-1411 Fax: (204) 237-3468 E-mail: info@cphm.ca Website: www.cphm.ca Manitoba Prescribing Practices Program
More informationCURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
More informationNEW/RENEWAL APPLICATION FOR PAIN MANAGEMENT CLINIC REGISTRATION
Department of Regulatory and Economic Resources Business Affairs Division Office of Consumer Protection 601 NW 1st Court, 18th Floor Miami, Florida 33136 Tel: 786-469-2300 Fax: 786-469-2311 email: license@miamidade.gov
More informationR 5530 SUBSTANCE ABUSE (M) [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204]
R 5530/Page 1 of 17 M R 5530 [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204] The following procedures are established in implementation of Policy 5530, Substance Abuse. A. Definitions
More informationMEMORANDUM. Employees. Human Resources AGENCY DRUG-FREE WORKPLACE POLICY
MEMORANDUM TO: FROM: RE: Employees Human Resources AGENCY DRUG-FREE WORKPLACE POLICY Attached is a copy of the Mississippi Department of Health s established Drug-Free Workplace Policy. This policy reflects
More informationGuidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
More informationExceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015
Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the
More informationDIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS
855-025-0001 DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS Purpose and Scope Transition from Registration of Technician to Licensure of Technician The purpose of the Pharmacy
More informationA BILL FOR AN ACT ENTITLED: "AN ACT ALLOWING A TERMINALLY ILL PATIENT TO REQUEST
SB00.0 SENATE BILL NO. 0 INTRODUCED BY DICK BARRETT A BILL FOR AN ACT ENTITLED: "AN ACT ALLOWING A TERMINALLY ILL PATIENT TO REQUEST MEDICATION TO END THE PATIENT'S LIFE; ESTABLISHING PROCEDURES; PROVIDING
More informationRobbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12
R Robbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12 R 5530 SUBSTANCE ABUSE (M) The following procedures are established in implementation
More informationPitfalls of Working in Family Medicine Presented by:
Pitfalls of Working in Family Medicine Presented by: www.thehealthlawfirm.com Main Office: 1101 Douglas Avenue Altamonte Springs, Florida 32714 Phone: (407) 331-6620 Fax: (407) 331-3030 Website: www.thehealthlawfirm.com
More informationNOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationPharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary
Pharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary Houston DEA Pharmacy Diversion Awareness Conference September 8 & 9, 2012
More informationSUPPLEMENTAL NOTE ON HOUSE BILL NO. 2577. HB 2577 would create the Addictions Counselor Licensure Act. The following is the outline of the Act:
Corrected SESSION OF 2010 SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2577 As Amended by House Committee on Health and Human Services Brief* HB 2577 would create the Addictions Counselor Licensure Act. The following
More informationTHE DOG ATE MY PRESCRIPTION! DRUG-SEEKING BEHAVIORS EVERY NURSE SHOULD KNOW Jill Hasley, MNSc., RN
THE DOG ATE MY PRESCRIPTION! DRUG-SEEKING BEHAVIORS EVERY NURSE SHOULD KNOW Jill Hasley, MNSc., RN What s the Problem? Los Angeles Times (2010): 57% of drug overdoses involved prescription drugs 74% of
More informationGeneric and Brand Name Drugs: Understanding the Basics
Generic and Brand Name Drugs: Understanding the Basics We ve been there. We can help. Joe has just been diagnosed with bipolar disorder. After talking to his doctor, he decides to see a therapist and go
More information155 McDonald Drive SW Shirley E. Charette, MS, PA-C
LAKELAND FAMILY MEDICINE Dennis J. Charette, M.D. 155 McDonald Drive SW Shirley E. Charette, MS, PA-C Carri A. Meiler, MS, PA-C Phone: 330-308-8999 Fax: 330-308-8016 www.lakelandfamilymedicine.com PATIENT
More informationADMINISTRATION OF MEDICATIONS POLICY
Policy 6.007. ADMINISTRATION OF MEDICATIONS POLICY It is the policy of Cooperative Educational Services (C.E.S.) that students who require any medications to be administered during school hours, including
More informationCMS Mandated Training for Providers, First Tier, Downstream and Related Entities
CMS Mandated Training for Providers, First Tier, Downstream and Related Entities I. INTRODUCTION It is the practice of Midwest Health Plan (MHP) to conduct its business with the highest degree of ethics
More informationACTION ITEM COMPLETED TAB 44
H.B. 1 H.B. 751 Provisions of the H.B. 1 Appropriations Act The base appropriation for TSBP for FY2016-2017 is approximately $234,000 more than the base appropriation the previous biennium. The majority
More informationA Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law
Knowledge replaces fear. A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Note: Though this article concerns requests made by federal Drug Enforcement Administration investigators
More informationPursuant to the authority vested in the Commissioner of Health by Article 33 of the
Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health
More informationMONITORING AGREEMENT Overview
MONITORING AGREEMENT Overview Voluntarily agree to participate in the Tennessee Professional Assistance Program (TnPAP) and adhere to the terms set forth in the Monitoring Agreement. Abstinence from Drugs
More informationDiscrepancies are claims that appear to have unusual or potentially abusive, wasteful or fraudulent elements (e.g., quantity, days supply).
Purpose: Provide guidelines for pharmacies for audits and appeals of pharmacy audit findings resulting from MedImpact auditor data review and claims selection for identification of potential fraud, waste
More informationALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE
ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-17 GUIDELINES AND STANDARDS FOR THE UTILIZATION OF CONTROLLED SUBSTANCES FOR WEIGHT REDUCTION TABLE OF CONTENTS 540-X-17-.01 540-X-17-.02
More informationRULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS
RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED NURSE PRACTITIONERS (CRNP) AND CERTIFIED
More informationTECHNICIAN-IN-TRAING IS NOT PERMITTED TO PRACTICE IN MONTANA IN ANY MANNER WITHOUT AN ACTIVE MONTANA REGISTRATION
Page 1 of 8 MONTANA BOARD OF PHARMACY (301 S PARK, 4 TH FLOOR, HELENA, MT 59601 - Delivery) P. O. Box 200513 Helena, Montana 59620-0513 PHONE (406) 841-2300 FAX (406) 841-2344 E-MAIL: dlibsdpha@mt.gov
More informationPain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to
Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations
More informationPrescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
More informationThe Medical Center regrets any inconvenience or problems that the policy may cause but believes that the overall benefit to the institution and its
Policy. The following rules represent the University of Mississippi Medical Center s policy concerning substance abuse. They are enforced uniformly with respect to all employees, as indicated: 1. All employees
More informationBuprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)
Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies
More informationControlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
More information1 2006. Williams, Kastner & Gibbs PLLC All Rights Reserved
Drug and Alcohol Records Acquisition and Storage in the Workplace by Kimberly D. Baker Despite the increase in education about and employee assistance directed to the avoidance and treatment of substance
More informationGEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)
GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;
More informationUnconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35)
Unconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35) Controlled Substance, Drug, Device And Cosmetic Act. 780-113. Prohibited acts; penalties (a) The following acts and the causing thereof
More informationAMERICAN NATIONAL INSURANCE COMPANY CREDIT INSURANCE DIVISION P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 800-899-6502
P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 DISABILITY CLAIM FORM INSTRUCTIONS Enclosed is a claim form required in order to process disability payments on your loan. It is important that all questions
More informationThe following procedures are established in implementation of Policy No. 5530, Substance Abuse.
R5530.DR Page 1 of 11 The following procedures are established in implementation of Policy No. 5530,. A. Definitions 1. Evaluation means those procedures used by a certified or licensed professional to
More information(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose)
ESSENTIAL ELEMENTS OF AN ELECTRONIC PRESCRIPTION MONITORING PROGRAM There currently is a wide variety of factors that characterize state electronic Prescription Monitoring Programs (PMPs), which originated
More informationFraud, Waste and Abuse Network Pharmacy Training 2011
Fraud, Waste and Abuse Network Pharmacy Training 2011 Table of Contents Centers for Medicare & Medicaid Services (CMS) Role Important Federal Statutes for Medicare Participants Fraud, Waste and Abuse Defined
More information